Turner Christopher Durant

Chief Medical Officer at NUVL

Sold, on record
$2.2M
Dollars the filings state
Form 4 sales
6
Latest Jan 6, 2026
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NUVLNuvalent, Inc.Chief Medical Officer

Sales by reason

6
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale NUVLRoutine
    Jul 24, 2023 2023

    Sold 300 shares at $46.81 ($14k)

    Turner Christopher Durant, Chief Medical Officer

    10b5-1 planSold 2% of holdings ($693k position)14,513 shares leftFollows a Form 144Filing

  2. 2 Form 4 sale NUVLRoutine
    Jul 28, 2023 +4 days

    Sold 5,030 shares at $47.95 ($241k)

    Turner Christopher Durant, Chief Medical Officer

    10b5-1 planSold 25.7% of holdings ($937k position)14,513 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice NUVLNotice
    Jul 28, 2023 same day

    Filed to sell 10,660 shares ($517k)

    Turner Christopher Durant, Officer

    10b5-1 planFiling

  4. 4 Form 4 sale NUVLRoutine
    Oct 4, 2023 +68 days

    Sold 7,995 shares at $54.04 ($432k)

    Turner Christopher Durant, Chief Medical Officer

    10b5-1 planSold 35.5% of holdings ($1.2M position)14,513 shares left1.6x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice NUVLNotice
    Jan 6, 2025 +460 days

    Filed to sell 4,250 shares ($343k)

    Turner Christopher Durant, Officer

    10b5-1 plan0.7x usual sizeFiling

  6. 6 Form 4 sale NUVLRoutine
    Jan 6, 2025 same day

    Sold 4,016 shares at $79.68 ($320k)

    Turner Christopher Durant, Chief Medical Officer

    10b5-1 planSold 6% of holdings ($5.3M position)62,547 shares left0.6x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice NUVLNotice
    Jan 5, 2026 +364 days

    Filed to sell 7,417 shares ($724k)

    Turner Christopher Durant, Officer

    10b5-1 planFiling

  8. 8 Form 4 sale NUVLRoutine
    Jan 6, 2026 +1 day

    Sold 7,417 shares at $97.25 ($721k)

    Turner Christopher Durant, Chief Medical Officer

    10b5-1 planSold 11.9% of holdings ($6.1M position)55,130 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Turner Christopher Durant
Source
Jan 6, 2026Jan 7, 2026NUVLChief Medical OfficerForm 4 sale7,417$721k11.9%RoutineSEC
Jan 5, 2026Jan 5, 2026NUVLOfficerForm 144 notice7,417$724kNoticeSEC
Jan 6, 2025Jan 8, 2025NUVLChief Medical OfficerForm 4 sale4,016$320k6.0%RoutineSEC
Jan 6, 2025Jan 6, 2025NUVLOfficerForm 144 notice4,250$343kNoticeSEC
Oct 4, 2023Oct 6, 2023NUVLChief Medical OfficerForm 4 sale7,995$432k35.5%RoutineSEC
Jul 28, 2023Jul 28, 2023NUVLOfficerForm 144 notice10,660$517kNoticeSEC
Jul 28, 2023Jul 28, 2023NUVLChief Medical OfficerForm 4 sale5,030$241k25.7%RoutineSEC
Jul 24, 2023Jul 24, 2023NUVLChief Medical OfficerForm 4 sale300$14k2.0%RoutineSEC
Jun 5, 2023Jun 7, 2023NUVLChief Medical OfficerForm 4 sale10,235$459k41.4%RoutineSEC
Jun 5, 2023Jun 5, 2023NUVLAffiliateForm 144 notice12,900$571kNoticeSEC